Hepcinat LP – Ledipasvir 90mg + Sofosbuvir 400mg Hepatitis C

Hepcinat LP (Ledipasvir / Sofosbuvir) (generic equivalent to Harvoni) is a prescription direct-acting antiviral (DAA) used to treat Chronic Hepatitis C Virus (HCV) infection. Modern DAA therapies like Hepcinat LP deliver cure rates exceeding 95% in most HCV genotypes.
Composition: Ledipasvir (90mg) + Sofosbuvir (400mg)
Treatment Course: Typically 8–12 weeks.
Manufacturer: Natco Pharma Ltd
Prescription-only antiviral. Use under the supervision of a hepatologist or infectious disease specialist. Baseline genotyping and viral load testing required before starting treatment.